Χώρα: Μάλτα
Γλώσσα: Αγγλικά
Πηγή: Medicines Authority
TERLIPRESSIN ACETATE
Ferring Pharmaceuticals Limited Drayton Hall, Church Road, West Drayton UB7 7PS, United Kingdom
H01BA04
TERLIPRESSIN ACETATE 1 mg
SOLUTION FOR INJECTION
TERLIPRESSIN ACETATE 1 mg
POM
PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
Withdrawn
2011-03-15
Page 1 of 4 PACKAGE LEAFLET: INFORMATION FOR THE USER GLYPRESSIN 1 MG SOLUTION FOR INJECTION Terlipressin acetate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor. - If you get any side effects talk to your doctor. This includesany possible side effects not listed in this leaflet. please tell your doctor. WHAT IS IN THIS LEAFLET : 1. What Glypressin is and what it is used for 2. What you need to know before you are given Glypressin 3. How you will be given Glypressin 4. Possible side effects 5. How to store Glypressin 6. Contents of the pack and other information 1. WHAT GLYPRESSIN IS AND WHAT IT IS USED FOR Glypressin solution for injection contains the active component terlipressin acetate. GLYPRESSIN IS USED IN THE TREATMENT OF BLEEDING OESOPHAGEAL VARICES . Oesophageal varices are enlarged blood vessels that form in the oesophagus (gullet) as a complication of liver disease. They may burst and bleed which is a serious and life-threatening condition. When injected into the bloodstream the active ingredient, terlipressin acetate, is broken down to release a substance called lysine vasopressin. This acts on the walls of the blood vessels, causing them to narrow and restrict blood flow so that bleeding is reduced. 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN GLYPRESSIN DO NOT USE GLYPRESSIN - if you are ALLERGIC (HYPERSENSITIVE) TO TERLIPRESSIN acetate or any of the other ingredients in Glypressin - if you are PREGNANT WARNING AND PRECAUTIONS - if you have HIGH BLOOD PRESSURE - if you have HEART DISEASE - in CHILDREN AND ELDERLY patients as experience is limited in these age groups - if you have SEPTIC SHOCK. Septic shock is a serious condition that occurs when a major infection leads to low blood pressure and low blood flow. TALK TO YOUR DOCTOR IF ANY OF THESE APPLY TO YOU BEFORE USING GLYPRESSIN. Page 2 of 4 During treatment with Glyp Διαβάστε το πλήρες έγγραφο
Page 1 of 5 1. NAME OF THE MEDICINAL PRODUCT Glypressin 1 mg solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ampoule of 8.5 ml solution contains 1 mg terlipressin acetate, corresponding to 0.85 mg terlipressin free base. The concentration of the solution is 0.12 mg terlipressin acetate/ml, corresponding to 0.1 mg terlipressin free base/ml. Excipients One ampoule contains 1.33 mmol (or 30.7 mg) sodium. _ _ For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for injection. Clear, colourless liquid. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Bleeding oesophageal varices 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _ _ _Adults:_ Initially an i.v. injection of 2 mg Glypressin solution for injection is given every 4 hours. The treatment should be maintained until bleeding has been controlled for 24 hours, but up to a maximum of 48 hours. After the initial dose, the dose can be adjusted to 1 mg i.v. every 4 hours in patients with body weight < 50 kg or if adverse effects occur. 4.3 CONTRAINDICATIONS Contraindicated in pregnancy. Hypersensitivity to terlipressin or to any of the excipients. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Blood pressure, heart rate and fluid balance should be monitored during treatment. To avoid local necrosis at the injection site, the injection must be given i.v. Caution should be exercised in treating patients with hypertension or recognised heart disease. Page 2 of 5 In patients with septic shock with a low cardiac output terlipressin should not be used. This medicinal product contains 1.33 mmol (or 30.7 mg) of sodium per ampoule. To be taken into consideration in patients on a controlled sodium diet. Children and the elderly: particular caution should be exercised in the treatment of children and elderly patients, as experience is limited in these groups. There are no data available regarding dosage recommendation in these special patient categories. 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERA Διαβάστε το πλήρες έγγραφο